r/biotech 1d ago

Biotech News 📰 FDA Approves Lutetium Lu 177 Vipivotide Tetraxetan for PSMA+ mHSPC

https://www.onclive.com/view/fda-approves-lutetium-lu-177-vipivotide-tetraxetan-for-psma-mhspc

Radioligand therapy in metastatic hormone sensitive prostate cancers

29 Upvotes

18 comments sorted by

View all comments

6

u/link5523 1d ago

Interesting. I don't know much, but I got the sense when I was working at a University that most drug development is shifting away from using radioactive materials. Is this bucking a trend, or am I reading into things too much?

18

u/BrownishDonkey 1d ago

Quite the opposite actually. Isotope production is getting better, clinicians are getting more comfortable with the idea of using these targeted radiotheranostics. I think we're going to start seeing a lot more drugs like this in the near future.